Every clinician wants the same thing: a fast, reliable answer to the clinical question in front of them. But "clinical question" is not a single category. The question "which SGLT2 inhibitor should I add to this multimorbid patient?" is fundamentally different from "what does the latest evidence say about GLP-1 agonists and cardiovascular outcomes?" and different again from "what does NICE recommend as the first-line treatment for gout?"
MetaGuideline, OpenEvidence, and iatroX each address one of these question types better than the others — and understanding which tool matches which question is more useful than ranking them on a single scoreboard.
MetaGuideline: Guideline Harmonisation for Prescribing
What it does best: Reconciles recommendations from multiple UK clinical guidelines for a single patient scenario, particularly for medication selection in cardiovascular and cardiometabolic multimorbidity. Its formal logic engine processes thousands of individual guideline recommendations and produces a synthesised prescribing recommendation.
Core strength: The intersection problem. When four NICE guidelines apply to one patient and their recommendations partially overlap, partially conflict, and partially condition on each other, MetaGuideline's logic engine does the reconciliation computationally.
Limitations: Currently cardiovascular-focused. Not a general clinical reference. Not grounded in primary research literature — it processes guidelines, not evidence. Not a learning or exam tool. £5.95/month.
Best question type: "Given this specific patient with these specific comorbidities and medications, which medication should I add or change according to UK guidelines?"
OpenEvidence: Literature-Based Evidence Synthesis
What it does best: Searches and synthesises peer-reviewed medical literature to answer clinical questions with evidence-grounded responses. Designed for verified healthcare professionals. Strong citation quality with links to primary research.
Core strength: Deep literature coverage. When the question goes beyond what a guideline covers — a newer treatment, a comparison not yet addressed by NICE, or an evidence question that requires understanding the primary research — OpenEvidence is stronger than guideline-based tools.
Limitations: The product is internationally oriented. Check current vendor documentation for exact source coverage rather than assuming inclusion of NICE, CKS or product-specific SmPCs on eMC. Professional verification may be required for access, and its published-literature answers may not align with UK-specific recommendations. Check the live product for current learning, Q-bank and CPD features.
Best question type: "What does the evidence say about X?" — where X is a clinical question that benefits from literature synthesis rather than guideline retrieval.
iatroX: UK-Guideline-First Clinical Reference with Learning
What it does best: Retrieves citation-first answers grounded in NICE, CKS and SIGN guidance, with medicines information from SmPCs via eMC. Provides a structured Knowledge Centre, a Brainstorm clinical reasoning tool, an adaptive Q-Bank with spaced repetition, and a CPD module.
Core strength: UK-oriented retrieval alongside learning tools. Ask iatroX can attach links to retrieved UK guidance and medicines information, while the Q-Bank and CPD features support learning workflows. Each citation and generated claim still requires verification.
Limitations: Does not perform the formal logic harmonisation of multiple guidelines that MetaGuideline provides. Does not offer the deep literature synthesis that OpenEvidence provides. It retrieves and explains guideline content; it does not reconcile conflicting guidelines computationally.
Best question type: "What does NICE recommend for X?" — where X is a specific clinical question that needs a fast, verified, guideline-grounded answer in UK practice.
The Decision Framework
| Question type | Best tool |
|---|---|
| Complex prescribing with multiple comorbidities (UK) | MetaGuideline |
| Evidence question requiring literature synthesis | OpenEvidence |
| UK guideline clarification or prescribing threshold | iatroX |
| Exam preparation and knowledge retention | iatroX Q-Bank |
| Clinical reasoning for complex cases | iatroX Brainstorm |
| CPD and professional development | iatroX CPD |
| Product-specific licensed information | Relevant SmPC on eMC, alongside the applicable clinical and local guidance |
The Complete Stack
For a UK clinician who manages complex patients, prepares for exams, and needs to maintain CPD, the complete stack is:
iatroX as the daily guideline reference, learning platform, and CPD engine. Free, UK-specific, always available.
MetaGuideline for complex cardiovascular prescribing harmonisation. £5.95/month, specialised and deep in its lane.
OpenEvidence for evidence questions that go beyond guideline coverage. Free for verified HCPs, literature-focused.
For a prescribing decision, verify the relevant SmPC on eMC and apply the appropriate NICE, SPS, local or specialist guidance.
Conclusion
MetaGuideline, OpenEvidence, and iatroX are not flat substitutes. They are three different answers to three different versions of the clinical question problem: prescribing harmonisation, evidence synthesis, and guideline retrieval with learning.
The clinician who understands which tool to reach for — and why — will get better answers, faster, than the clinician who expects one tool to do everything.